Demonstrates efficient fisetin glycoside production using a novel enzyme in engineered cells, indicating potential for enhanced applications.
Fisetin is a natural polyhydroxyl flavonoid with anti-inflammatory, antioxidant, and neuroprotective activities, but its application in foods and agriculture is limited by poor stability, low absorption, and low bioavailability. Glycosylation can effectively improve its physicochemical and biological properties. Enzymatic glycosylation is attractive owing to its green, efficient, and highly specific features. In this study, a novel glycosyltransferase AaUGT from Arabis alpina was cloned and expressed in Escherichia coli . It showed optimal activity at 45 °C and pH 7.5, strict 3-O regioselectivity, and high catalytic efficiency ( K m = 0.37 mM, k cat / K m = 1884.18 M –1 s –1 ). By strengthening uridine diphosphate glucose (UDPG) supply via metabolic engineering, an efficient whole-cell system was constructed. Under optimized conditions, the titer of fisetin-3-O-glucoside reached 3.51 g/L with a conversion rate of 89.6%. This work supports the development of fisetin glycosides and provides a reference for flavonoid glycoside biosynthesis.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: